Angiotech Pharmaceuticals, Inc. Product Pipeline Analysis

Publication Date	August 2008
Publisher	Global Markets Direct
Product Type	Report
Pages	86
ISBN Number	not applicable
Product Code	GMD04784

Buy this product or for assistance call +44 20 7060 7474

PDF £450.00$749 | €504

FAX Order above formats by FAX

Summary

This report is an insightful source for data, analysis and strategic insights into a Angiotech Pharmaceuticals, Inc.'s pipeline and investigational products. The report also provides details on clinical trials covering trial phase, description, investigator information, primary and secondary end-points and trial results for products in development.

Scope

Details of development stage by sector and equipment type.
Pipeline products grouped by therapy area, development stage and trial phase.
Detailed information on clinical trials covering trial phase, description, investigator .nformation, primary and secondary end-points and trial results.
Trial updates, trial start and end dates, patient numbers and the trials primary outcome measures, secondary outcome measures.
Product updates covering estimated approval dates and estimated launch dates.
Descriptions of novel technologies relating to pipeline products of the company.
Patents and patent applications covered for the product.
News updates on key events relating to the product and its development.

Reasons to buy

A single source to fulfill competitor information relating to products in development.
Identify pipeline products that are potential competitor to your product lines.

Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline.

Access clinical trial information to map trial results and plan targeted marketing activities.
Take corrective measures on your own development programs and R&D initiatives based on regulatory events of competitor product pipelines.
Identification of potential investment opportunities.
Build up knowledge base for potential distribution and marketing partners.
Helps avoid patent infringement.
Timelines from concept to market lets you keep track of market potential build for a new product.

Assess a company's future growth by determining its pipeline depth, for probable acquisition opportunities.

Content

1 List of Tables
- 1.2 List of Figures
2 Company Snapshot
- 2.1 Key Information
- 2.2 Company Overview
- 2.3 Industry Outlook Cardiovascular Devices
3 Business Description
- 3.1 Business Overview
- 3.2 Major Products and Services
  - 3.2.1 Overview
4 History
5 Competitors
6 Key Employees
7 Key Employee Biographies
8 Company Statement
9 Locations And Subsidiaries
- 9.1 Head Office
- 9.2 Other Locations & Subsidiaries
10 Recent Developments
- 10.1 Strategy And Business Planning
  - 10.1.1 Jun 12, 2007: Angiotech, CombinatoRx Extend Research Collaboration
- 10.2 Financial Announcements
  - 10.2.1 Jul 28, 2008: Angiotech Declares 2Q 2008 Results
  - 10.2.2 Jul 15, 2008: Angiotech To Declare 2Q 2008 Results
  - 10.2.3 Apr 29, 2008: Angiotech Declares Q1 2008 Results
  - 10.2.4 Feb 14, 2008: Angiotech Declares Q4 2007 Results
  - 10.2.5 Nov 01, 2007: Angiotech Declares Q3 2007 Results
  - 10.2.6 Aug 02, 2007: Angiotech Declares Q2 2007 Results
  - 10.2.7 May 02, 2007: Angiotech Declares Q1 2007 Results
  - 10.2.8 Feb 01, 2007: Angiotech Declares Q4 2006 Results
  - 10.2.9 Nov 01, 2006: Angiotech Declares Q3 2006 Results
  - 10.2.10 Aug 03, 2006: Angiotech Declares Q2 2006 Results
- 10.3 Research And Development
  - 10.3.1 Jun 12, 2007: Angiotech, CombinatoRx Extend Research Collaboration
- 10.4 Corporate Communications
  - 10.4.1 May 13, 2008: Angiotech Appoints New Board Member
  - 10.4.2 Apr 15, 2008: Angiotech Director Resigns
  - 10.4.3 Aug 02, 2007: Angiotech Appoints New Board Member
- 10.5 Legal and Regulatory
  - 10.5.1 Jul 10, 2008: Angiotech Wins Before The UK House Of Lords
- 10.6 Product News
  - 10.6.1 Aug 12, 2008: Angiotech Pharmaceuticals Receives CE Mark Approval Of HemoStream Chronic Dialysis Catheter
  - 10.6.2 Jun 12, 2008: Angiotech Pharmaceuticals Announces Market Launch Of Quill SRS MONODERM
  - 10.6.3 Jun 03, 2008: Angiotech Pharmaceuticals Announces Completion Of Bio-Seal Clinical Trial Enrolment
  - 10.6.4 May 01, 2008: Angiotech Expands Quill SRS Product Offering Receiving FDA 510(k) Approval For Smaller Size Diameters Of Quill SRS PDO
  - 10.6.5 Apr 21, 2008: Angiotech Elects To Suspend Vascular Wrap Pivotal Clinical Trials
  - 10.6.6 Apr 21, 2008: Angiotech Pharmaceuticals, Inc. Elects To Suspend Vascular Wrap Pivotal Clinical Trials
  - 10.6.7 Apr 17, 2008: Angiotech 5-FU Central Venous Catheter Receives FDA 510(k) Clearance
  - 10.6.8 Mar 18, 2008: 960-Patient Study Demonstrates Zero Blood Stream Infection In Patients Treated With Angiotech's Novel 5-FU Central Venous Catheter
  - 10.6.9 Mar 18, 2008: Study Successfully Hit Primary End Point
  - 10.6.10 Mar 13, 2008: Angiotech Showcases Hemostream Dialysis Catheter At The Society Of Interventional Radiology Annual Meeting
  - 10.6.11 Jan 03, 2008: FDA Gives Athersys Green Light For AMI Drug Trial
  - 10.6.12 Dec 20, 2007: Athersys And Angiotech Announce Authorization Of Phase I Intramyocardial Stem Cell US Clinical Trial In Acute Myocardial Infarction
  - 10.6.13 Jul 10, 2007: Angiotech Completes Enrollment In Its Central Venous Catheter Pivotal Study
  - 10.6.14 May 30, 2007: Angiotech Initiates European Trial Examining The Vascular Wrap Paclitaxel-Eluting Mesh For Dialysis Patients With End-Stage Renal Disease
  - 10.6.15 May 29, 2007: Angiotech Initiates European Trial Examining The Vascular Wrap Paclitaxel-Eluting Mesh For Dialysis Patients With End-Stage Renal Disease
  - 10.6.16 May 10, 2007: Angiotech To Market Vascular Wrap /e0PTFE Graft Combination Product Through Its Own European Sales And Distribution Networks
  - 10.6.17 Apr 26, 2007: Two-Year Data For Angiotechs Vascular Wrap Paclitaxel-Eluting Mesh To Be Presented At European Vascular Symposium
  - 10.6.18 Mar 19, 2007: Angiotech Initiates US Pivotal Trial For The Vascular Wrap Paclitaxel-Eluting Mesh
  - 10.6.19 Mar 19, 2007: ANGIOTECH Initiates US Pivotal Trial For The Vascular Wrap Paclitaxel-Eluting Mesh
  - 10.6.20 Nov 16, 2006: Angiotech Submits Application For European Regulatory Approval For Its Vascular Wrap Product
  - 10.6.21 Nov 16, 2006: Angiotech Submits Application For European Regulatory Approval For Its Vascular Wrap Product
  - 10.6.22 Nov 09, 2006: Angiotech's Vascular Wrap Trial Results Demonstrate Reduced Incidence Of Amputation
  - 10.6.23 Nov 09, 2006: Angiotech's Vascular Wrap Trial Results Demonstrate Reduced Incidence Of Amputation
  - 10.6.24 Sep 17, 2006: Positive Preclinical Data On Vascular Wrap Presented At Vascular Conference
  - 10.6.25 Sep 17, 2006: Positive Preclinical Data On Vascular Wrap Presented At Vascular Conference
  - 10.6.26 Apr 07, 2006: Angiotech Presents Positive Adhibit Data At The 19th Annual European Congress Of Obstetrics And Gynecology
  - 10.6.27 Nov 17, 2005: Angiotech Pharmaceuticals Announces Positive Interim Safety Data With Vascular Wrap At One year
  - 10.6.28 Sep 28, 2005: Angiotech Announces Positive Adhibit Data To Prevent Surgical Adhesions
  - 10.6.29 Aug 31, 2004: Angiotech Completes Enrolment In Vascular Wrap Study Ahead Of Schedule.(Research Alert)
- 10.7 Product Approvals
  - 10.7.1 Aug 12, 2008: Angiotech Pharmaceuticals Receives CE Mark Approval Of HemoStream Chronic Dialysis Catheter
  - 10.7.2 May 01, 2008: Angiotech Expands Quill SRS Product Offering Receiving FDA 510(k) Approval For Smaller Size Diameters Of Quill SRS PDO
  - 10.7.3 Apr 17, 2008: Angiotech 5-FU Central Venous Catheter Receives FDA 510(k) Clearance
- 10.8 Clinical Trials
  - 10.8.1 Jun 03, 2008: Angiotech Pharmaceuticals Announces Completion Of Bio-Seal Clinical Trial Enrolment
  - 10.8.2 Apr 21, 2008: Angiotech Pharmaceuticals, Inc. Elects To Suspend Vascular Wrap Pivotal Clinical Trials
  - 10.8.3 Apr 21, 2008: Angiotech Elects To Suspend Vascular Wrap Pivotal Clinical Trials
  - 10.8.4 Mar 18, 2008: Study Successfully Hit Primary End Point
  - 10.8.5 Jan 03, 2008: FDA Gives Athersys Green Light For AMI Drug Trial
  - 10.8.6 Dec 20, 2007: Athersys And Angiotech Announce Authorization Of Phase I Intramyocardial Stem Cell US Clinical Trial In Acute Myocardial Infarction
  - 10.8.7 Jul 10, 2007: Angiotech Completes Enrollment In Its Central Venous Catheter Pivotal Study
  - 10.8.8 May 30, 2007: Angiotech Initiates European Trial Examining The Vascular Wrap Paclitaxel-Eluting Mesh For Dialysis Patients With End-Stage Renal Disease
  - 10.8.9 May 29, 2007: Angiotech Initiates European Trial Examining The Vascular Wrap Paclitaxel-Eluting Mesh For Dialysis Patients With End-Stage Renal Disease
  - 10.8.10 Apr 26, 2007: Two-Year Data For Angiotechs Vascular Wrap Paclitaxel-Eluting Mesh To Be Presented At European Vascular Symposium
  - 10.8.11 Mar 19, 2007: ANGIOTECH Initiates US Pivotal Trial For The Vascular Wrap Paclitaxel-Eluting Mesh
  - 10.8.12 Mar 19, 2007: Angiotech Initiates US Pivotal Trial For The Vascular Wrap Paclitaxel-Eluting Mesh
  - 10.8.13 Nov 09, 2006: Angiotech's Vascular Wrap Trial Results Demonstrate Reduced Incidence Of Amputation
  - 10.8.14 Nov 09, 2006: Angiotech's Vascular Wrap Trial Results Demonstrate Reduced Incidence Of Amputation
  - 10.8.15 Sep 17, 2006: Positive Preclinical Data On Vascular Wrap Presented At Vascular Conference
  - 10.8.16 Sep 17, 2006: Positive Preclinical Data On Vascular Wrap Presented At Vascular Conference
  - 10.8.17 Apr 07, 2006: Angiotech Presents Positive Adhibit Data At The 19th Annual European Congress Of Obstetrics And Gynecology
  - 10.8.18 Nov 17, 2005: Angiotech Pharmaceuticals Announces Positive Interim Safety Data With Vascular Wrap At One year
  - 10.8.19 Sep 28, 2005: Angiotech Announces Positive Adhibit Data To Prevent Surgical Adhesions
  - 10.8.20 Aug 31, 2004: Angiotech Completes Enrolment In Vascular Wrap Study Ahead Of Schedule.(Research Alert)
11 Angiotech Pharmaceuticals, Inc. Pipeline Products
- 11.1 Angiotech Pharmaceuticals, Inc. Product Pipeline Analysis
  - 11.1.1 Angiotech Pharmaceuticals, Inc. Pipeline Products By Equipment Type
  - 11.1.2 Angiotech Pharmaceuticals, Inc. Pipeline Products By Development Stage
  - 11.1.3 Angiotech Pharmaceuticals, Inc. Pipeline Products By Therapy Area
  - 11.1.4 Angiotech Pharmaceuticals, Inc. Pipeline Products By Clinical Trials
  - 11.1.5 Angiotech Pharmaceuticals, Inc. Pipeline Products By News Summary
- 11.2 5-FU Central Venous Catheter
  - 11.2.1 Product Description
  - 11.2.2 Product Status
  - 11.2.3 Clinical Trials
  - 11.2.4 Product Milestone
  - 11.2.5 Product Patent Details
- 11.3 Vascular Wrap
  - 11.3.1 Product Description
  - 11.3.2 Product Status
  - 11.3.3 Clinical Trials
  - 11.3.4 Product Milestone
  - 11.3.5 Product Patent Details
  - 11.3.6 Product Patent Details
  - 11.3.7 Product Patent Details
  - 11.3.8 Product Patent Details
  - 11.3.9 Product Patent Details
  - 11.3.10 Product Patent Details
  - 11.3.11 Product Patent Details
  - 11.3.12 Product Patent Details
  - 11.3.13 Product Patent Details
- 11.4 MultiStem
  - 11.4.1 Product Description
  - 11.4.2 Product Status
  - 11.4.3 Clinical Trials
  - 11.4.4 Product Milestone
- 11.5 BioSeal Plug
  - 11.5.1 Product Description
  - 11.5.2 Product Status
  - 11.5.3 Clinical Trials
  - 11.5.4 Product Milestone
- 11.6 Adhibit
  - 11.6.1 Product Description
  - 11.6.2 Product Status
  - 11.6.3 Clinical Trials
  - 11.6.4 Product Milestone
- 11.7 5-FU Anti-Infective Dialysis Catheter
  - 11.7.1 Product Description
  - 11.7.2 Product Status
- 11.8 Vascular Wrap paclitaxel-eluting mesh
  - 11.8.1 Product Description
  - 11.8.2 Product Status
  - 11.8.3 Clinical Trials
  - 11.8.4 Product Milestone
12 Appendix
- 12.1 Methodology
  - 12.1.1 Coverage
  - 12.1.2 Secondary Research
  - 12.1.3 Primary Research
  - 12.1.4 Expert Panel Validation
- 12.2 Contact Us
- 12.3 About Global Markets Direct
- 12.4 Disclaimer
1 List of Tables
- Table 1: Angiotech Pharmaceuticals, Inc.,Key Facts
- Table 2: Angiotech Pharmaceuticals, Inc., Key Employees,
- Table 3: Angiotech Pharmaceuticals, Inc., Other Locations
- Table 4: Angiotech Pharmaceuticals, Inc., Subsidiaries
- Table 5: Angiotech Pharmaceuticals, Inc. Pipeline Products by Equipment Type
- Table 6: Angiotech Pharmaceuticals, Inc. Pipeline Products By Development Stage
- Table 7: Angiotech Pharmaceuticals, Inc. Pipeline Products By Therapy Area
- Table 8: Angiotech Pharmaceuticals, Inc. Pipeline Products By Clinical Trials
- Table 9: Angiotech Pharmaceuticals, Inc. Pipeline Products By News Summaries
- 1.2 List of Figures
- Figure 1: Angiotech Pharmaceuticals, Inc. Pipeline Products By Equipment Type
- Figure 2: Angiotech Pharmaceuticals, Inc. Pipeline Products By Equipment Type
- Figure 3: Angiotech Pharmaceuticals, Inc. Pipeline Products By Development Stage
- Figure 4: Angiotech Pharmaceuticals, Inc. Pipeline Products By Clinical Trials
- Figure 5: Angiotech Pharmaceuticals, Inc. Pipeline Products By News Summary
- Figure 6: Global Markets Direct Methodology